Viridian Therapeutics, Inc. (VRDN)
29.40
+1.33
(+4.74%)
USD |
NASDAQ |
Feb 24, 16:00
29.98
+0.58
(+1.97%)
Pre-Market: 09:17
Viridian Therapeutics Shareholders Equity (Annual) : 671.64M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Marker Therapeutics, Inc. | 18.56M |
| ADMA Biologics, Inc. | 349.02M |
| Avantor, Inc. | 5.565B |
| Immunovant, Inc. | 707.45M |
| Plus Therapeutics, Inc. | -8.949M |